Lunai Bioworks (RENB) announced advancement of its biomarker discovery preclinical program in Parkinson’s Disease. The initiative leverages BioSymetrics’ proprietary Augusta Platform to unlock novel ...
The software also detected the ‘sequence effect’ in both iRBD and Parkinson’s patients—a progressive decline in movement speed and amplitude during repetitive actions. This effect could serve as an ...
Globally recognized figures like Muhammad Ali and Michael J. Fox have long suffered from Parkinson's disease. The disease ...
Medtronic (NYSE: MDT) today announced study results backing its adaptive DBS algorithm for personalized therapy in ...
Recently FDA-cleared, adaptive deep brain stimulation is gaining global traction, offering real-time, personalized therapy ...
16hon MSN
Machine learning and cell imaging combine to predict effectiveness of multiple sclerosis medication
Brazilian researchers, in partnership with French institutions, have developed a tool that can predict how patients will respond to natalizumab, one of the most commonly used drugs for treating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback